arginyl-glycyl-aspartic acid has been researched along with Diabetic Retinopathy in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beets, K; Etienne, I; Feyen, JHM; Hu, TT; Stitt, AW; Van Bergen, T; Van Hove, I; Vermassen, E | 1 |
| Feng, D; Li, L; Li, Y; Li, Z; Sheng, J; Wang, A; Wang, F; Yin, F; Zhang, X | 1 |
| Bhatwadekar, AD; Curtis, TM; Gardiner, TA; Glenn, JV; Li, G; Stitt, AW | 1 |
| Bretzel, RG; Brownlee, M; Chavakis, E; Hammes, HP; Linn, T; Preissner, KT; Riecke, B | 1 |
| Bretzel, RG; Brownlee, M; Chavakis, E; Hammes, HP; Lin, J; Linn, T; Preissner, KT; Riecke, B | 1 |
1 review(s) available for arginyl-glycyl-aspartic acid and Diabetic Retinopathy
| Article | Year |
|---|---|
Targeting RGD-binding integrins as an integrative therapy for diabetic retinopathy and neovascular age-related macular degeneration.
Topics: Angiogenesis Inhibitors; Diabetes Mellitus; Diabetic Retinopathy; Humans; Integrins; Macular Edema; Oligopeptides; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration | 2021 |
1 trial(s) available for arginyl-glycyl-aspartic acid and Diabetic Retinopathy
| Article | Year |
|---|---|
Topical application of integrin antagonists inhibits proliferative retinopathy.
Topics: Adhesiveness; Administration, Topical; Animals; Diabetic Retinopathy; Hypoxia; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Oligopeptides; Ophthalmic Solutions; Receptors, Vitronectin; Retina | 2001 |
3 other study(ies) available for arginyl-glycyl-aspartic acid and Diabetic Retinopathy
| Article | Year |
|---|---|
Tat PTD-Endostatin-RGD: A novel protein with anti-angiogenesis effect in retina via eye drops.
Topics: Animals; Blood-Retinal Barrier; Chick Embryo; Chorioallantoic Membrane; Diabetic Retinopathy; Endostatins; Humans; Integrin alphaVbeta3; Mice; Neovascularization, Pathologic; Oligopeptides; Ophthalmic Solutions; Rats; Recombinant Fusion Proteins; Retina; Retinal Neovascularization; Retinal Vessels; S-Nitroso-N-Acetylpenicillamine | 2016 |
Advanced glycation of fibronectin impairs vascular repair by endothelial progenitor cells: implications for vasodegeneration in diabetic retinopathy.
Topics: Animals; Cattle; Cell Adhesion; Cell Movement; Chemokine CXCL12; Chemotaxis; Diabetic Retinopathy; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Fibronectins; Flow Cytometry; Glycation End Products, Advanced; Humans; Immunohistochemistry; Oligopeptides; Pyruvaldehyde; Retinal Vessels; Stem Cells; Wound Healing | 2008 |
Kinetics of integrin expression in the mouse model of proliferative retinopathy and success of secondary intervention with cyclic RGD peptides.
Topics: Animals; Diabetic Retinopathy; Disease Models, Animal; Integrins; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Oligopeptides; Peptides, Cyclic; Platelet Aggregation Inhibitors; Retinal Vessels | 2002 |